Medicine and Dentistry
Neoplasm
100%
Transitional Cell Carcinoma
85%
Cystectomy
55%
Bladder Cancer
50%
Non Muscle Invasive Bladder Cancer
40%
Recurrent Disease
39%
Lymphovascular Invasion
38%
Bacilli
34%
Nephroureterectomy
34%
Programmed Cell Death
33%
Adrenalectomy
33%
Neoadjuvant Chemotherapy
28%
Recurrence Free Survival
22%
Laparoendoscopic Single Site Surgery
19%
Bladder Tumor
18%
Pneumoperitoneum
18%
Transurethral Resection
18%
Diagnosis
18%
Hazard Ratio
18%
Randomized Controlled Trial
16%
Ureter
16%
Muscle Invasive Bladder Cancer
16%
Radical Nephrectomy
16%
Nivolumab
16%
Clear Cell Renal Cell Carcinoma
16%
Renal Artery
16%
Ureter Tumor
16%
Sarcopenia
16%
Cyanoacrylic Acid Octyl Ester
16%
Mycobacterium avium
16%
Risk Stratification
16%
Learning Curve
16%
Long Untranslated RNA
16%
Hybridization Chain Reaction
16%
Retrocaval Ureter
16%
Fistula
16%
Operation Duration
16%
Anatomy
16%
Perineum
16%
Skin Infection
16%
3D Imaging
16%
Prostate Cancer
16%
Multiparametric Magnetic Resonance Imaging
16%
Immunity
16%
Fibroblast Growth Factor Receptor 3
16%
Ureter Stricture
16%
Survival Rate
15%
Nephrectomy
13%
Protein S6
13%
Multivariate Analysis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Muscle Invasive Bladder Cancer
56%
Bacilli
50%
Neoplasm
46%
Programmed Cell Death
38%
Recurrent Disease
35%
Transitional Cell Carcinoma
35%
Bladder Cancer
33%
Chemotherapy
33%
Lymph Vessel Metastasis
20%
Recurrence Free Survival
19%
Bladder Tumor
18%
Castration Resistant Prostate Cancer
16%
Androgen Receptor
16%
Muscle Invasive Bladder Cancer
16%
Cotrimoxazole
16%
Nivolumab
16%
Ureter Tumor
16%
Disease
12%
Prostatitis
11%
Survival Rate
10%
Androgen
7%
Metastasis
5%
Keyphrases
Programmed Death-ligand 1 (PD-L1)
33%
Non-muscle Invasive Bladder Cancer (NMIBC)
33%
Tumor
28%
Clinical Outcomes
19%
Cancer Patients
18%
Bladder Cancer
16%
Nephroureterectomy
16%
Single-cell Imaging
16%
Upper Tract Urothelial Carcinoma
16%
T Cell Heterogeneity
16%
Hybridization Chain Reaction
16%
Bacillus
16%
Prognostic Impact
16%
Recurring
16%
Muscle-invasive Bladder Cancer
16%
Radical Cystectomy
16%
Ureteral Invasion
16%
Tumor Budding
16%
Ureteral Reimplantation
16%
Secondary Sarcopenia
16%
Clinical Role
16%
Ureteral Margin
16%
Ureteral Stricture
16%
Spatial Niche
8%
Quantitative Single-cell Analysis
8%
Coding RNA
8%
Endoscopy Biopsy
6%
Hazard Ratio
6%
Tumor Periphery
5%
Penile Graft
5%
Retrograde Ureteroscopy
5%
